Determinants of Use of Biotherapeutics in sub-Saharan Africa

Rajiv Shah, Dzifa Dey, Thomas Pietzonka, Paul Obeng, Bisola Ashiru, Martin Schiestl, Andrew Cavey, Edwin Nkansah, Guerric Radiere, Jonathan Spector, Christiaan Scott

Research output: Contribution to journalReview articlepeer-review

11 Citations (Scopus)

Abstract

Biologic drugs are reshaping clinical practice in various disciplines, even while access to them is imbalanced across global settings. In sub-Saharan Africa, biotherapeutics have potential roles to play in the treatment of a range of conditions that include infectious and noncommunicable diseases (NCDs). However, the literature is scarce on guidance for addressing local access challenges, including technical, regulatory, affordability, and other healthcare delivery aspects. This article aims to assess fundamental determinants of use of biologic medicines in sub-Saharan Africa. The purpose is to inform strategic actions of scientists, physicians, policymakers, and other stakeholders that are working to improve access to innovative therapies in low resource parts of the world.

Original languageEnglish
Pages (from-to)75-84
Number of pages10
JournalTrends in Pharmacological Sciences
Volume42
Issue number2
DOIs
Publication statusPublished - Feb 2021

Keywords

  • biologic medicines
  • healthcare delivery
  • sub-Saharan Africa

Fingerprint

Dive into the research topics of 'Determinants of Use of Biotherapeutics in sub-Saharan Africa'. Together they form a unique fingerprint.

Cite this